Adipose tissue quantification and primary graft dysfunction after lung transplantation: The Lung Transplant Body Composition study.


Journal Article

BACKGROUND: Obesity is associated with an increased risk of primary graft dysfunction (PGD) after lung transplantation. The contribution of specific adipose tissue depots is unknown. METHODS: We performed a prospective cohort study of adult lung transplant recipients at 4 U.S. transplant centers. We measured cross-sectional areas of subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT) on chest and abdominal computed tomography (CT) scans and indexed each measurement to height.2 We used logistic regression to examine the associations of adipose indices and adipose classes with grade 3 PGD at 48 or 72 hours, and Cox proportional hazards models to examine survival. We used latent class analyses to identify the patterns of adipose distribution. We examined the associations of adipose indices with plasma biomarkers of obesity and PGD. RESULTS: A total of 262 and 117 subjects had available chest CT scans and underwent protocol abdominal CT scans, respectively. In the adjusted models, a greater abdominal SAT index was associated with an increased risk of PGD (odds ratio 1.9, 95% CI 1.02-3.4, p = 0.04) but not with survival time. VAT indices were not associated with PGD risk or survival time. A greater abdominal SAT index correlated with greater pre- and post-transplant leptin (r = 0.61, p < 0.001, and r = 0.44, p < 0.001), pre-transplant IL-1RA (r = 0.25, p = 0.04), and post-transplant ICAM-1 (r = 0.25, p = 0.04). We identified 3 latent patterns of adiposity. The class defined by high thoracic and abdominal SAT had the greatest risk of PGD. CONCLUSIONS: Subcutaneous, but not visceral, adiposity is associated with an increased risk of PGD after lung transplantation.

Full Text

Duke Authors

Cited Authors

  • Anderson, MR; Udupa, JK; Edwin, E; Diamond, JM; Singer, JP; Kukreja, J; Hays, SR; Greenland, JR; Ferrante, A; Lippel, M; Blue, T; McBurnie, A; Oyster, M; Kalman, L; Rushefski, M; Wu, C; Pednekar, G; Liu, W; Arcasoy, S; Sonett, J; D'Ovidio, F; Bacchetta, M; Newell, JD; Torigian, D; Cantu, E; Farber, DL; Giles, JT; Tong, Y; Palmer, S; Ware, LB; Hancock, WW; Christie, JD; Lederer, DJ

Published Date

  • December 2019

Published In

Volume / Issue

  • 38 / 12

Start / End Page

  • 1246 - 1256

PubMed ID

  • 31474492

Pubmed Central ID

  • 31474492

Electronic International Standard Serial Number (EISSN)

  • 1557-3117

Digital Object Identifier (DOI)

  • 10.1016/j.healun.2019.08.013


  • eng

Conference Location

  • United States